Pediatric News - Oral nystatin cuts neonatal Candida risk
January 1, 2006 -- ST. LOUIS -- A medical practice intervention reduced the incidence of Candida species from 36% among 45 control neonates admitted between Jan. 1,...
Business Wire - UDL Receives Nystatin Approval
June 30, 1998 -- PITTSBURGH--(BUSINESS WIRE)--June 30, 1998--Mylan Laboratories Inc. (NYSE:MYL) announced today that its wholly owned subsidiary, UDL Laboratories...
Market Wire - Pacgen Reports First Quarter Financial Results
August 30, 2008 -- Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX VENTURE: PGA) today reported financial results from its first fiscal quarter...
Journal of Family Practice - What is the best treatment for oral thrush in healthy infants?
July 1, 2008 -- Evidence-based answer Nystatin oral suspension is a safe first-line therapy; fluconazole is more effective (strength of recommendation [SOR]: B, 1...
Market Wire - Pacgen Reports Fiscal 2008 Financial Results
July 29, 2008 -- Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX VENTURE: PGA) today reported financial results from its fiscal year ended...
Market Wire - Pacgen Announces Positive Results From Phase IIb Dose-Ranging Trial of PAC-113
June 5, 2008 -- Pacgen Biopharmaceuticals Corporation ("Pacgen") (TSX VENTURE: PGA) today announced positive results from its Phase IIb dose-ranging trial of...
Age and Ageing - A Pilot Study Comparing Nystatin And Fluconazole For Oral Candidiasis In Older People
July 1, 2001 -- Introduction...
Canadian Corporate News - Pacgen Initiates a Phase IIb Clinical Trial For PAC-113.
November 19, 2007 -- VANCOUVER, BRITISH COLUMBIA, Nov 19, 2007 (Marketwire via COMTEX) -- Pacgen Biopharmaceuticals Corporation ("Pacgen") (TSX VENTURE:PGA)...
Market Wire - Pacgen Initiates a Phase IIb Clinical Trial For PAC-113
November 19, 2007 -- Pacgen Biopharmaceuticals Corporation ("Pacgen") (TSX VENTURE: PGA) has initiated a Phase IIb dose-ranging clinical trial for an optimized...
Pharmacy News - Compounder barred.
July 19, 2007 -- Tegan Fleming A VICTORIAN pharmacist has been deregistered after a patient suffered a severe allergic reaction to a mouth ulcer gel made in his...
